Clinical Activity of Mcla-128 (Zenocutuzumab) in Combination with Endocrine Therapy (Et) in Er+/Her2-Low, Non-Amplified Metastatic Breast Cancer (Mbc) Patients (Pts) with Et-Resistant Disease Who Had Progressed on a Cdk4/6 Inhibitor (Cdk4/6I).

AuthID
 P-00S-VCJ
20
Author(s)
Pistilli, B
·
Hamilton, EP
·
Ferreira, AA
·
Dalenc, F
·
Vidal, M
·
Gavila, J
·
Goncalves, A
·
Murias, C
·
Mouret Reynier, MA
·
Canon, JLR
·
Bazan, F
·
Ladoire, S
·
Stalbovskaya, V
·
Murat, A
·
Ford, J
·
Bidard, FC
Document Type
Abstract
Year published
2020
Published
in JOURNAL OF CLINICAL ONCOLOGY, ISSN: 0732-183X
Volume: 38, Issue: 15
Indexing
Wos®
Publication Identifiers
Wos: WOS:000560368300207
Source Identifiers
ISSN: 0732-183X
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.

footer slogan

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service